Skip to content

Addiction: all studies

Page 404 of 857: studies 4,031 to 4,040 of 8,563, newest first. Back to the addiction overview

Research

The need for establishing best practices and gold standards in psychedelic medicine.

Journal of Affective Disorders July 1, 2023 Allison A. Feduccia, Gabby Agin-Liebes, Collin M. Price et al. 38 citations

Psychedelic substances are under investigation in several drug development programs. Controlled clinical trials are providing evidence for safe and effective use of psychedelic therapies for treating mental health conditions. With the anticipated FDA approval of MDMA-assisted therapy for posttraumatic stress disorder in 2023 and psilocybin therapy for depression disorders soon after, now is the...

The molecular basis of the antidepressant action of the magic mushroom extract, psilocin.

Biochimica et Biophysica Acta. Proteins and Proteomics July 1, 2023 Ali Asghar Hakami Zanjani, Teresa Quynh Tram Nguyen, Luise Jacobsen et al. 6 citations

Magic mushrooms, and their extract psilocybin, are well-known for their psychedelic properties and recreational use. Psilocin, the bio-active form of psilocybin, can potentially treat various psychiatric diseases. Psilocin putatively exerts its psychedelic effect as an agonist to the serotonin 2A receptor (5-HT2AR), which is also the receptor for the neurological hormone serotonin. The two key...

Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review

Journal of Psychopharmacology July 1, 2023 Oliver Rumle Hovmand, Emil Deleuran Poulsen, Sidse Arnfred et al. 52 citations

Background: The classical psychedelics, psilocybin, peyote, ayahuasca/ N,N-dimethyltryptamine, and lysergic acid diethylamide are considered promising new treatments for psychiatric illnesses, such as depression, anxiety, addiction, and obsessive-compulsive disorders. However, their profound and characteristic subjective effects raise concern for distinctive biases in randomized clinical...

DOI: 10.1177/02698811231180276 (opens in new tab) Randomized controlled trial Clinical trial Medline Clinical psychology

Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial

BJPsych Open July 1, 2023 Muhammad Ishrat Husain, Nicole Ledwos, Elise Fellows et al. 41 citations

Background Randomised controlled trials (RCTs) of psilocybin have reported large antidepressant effects in adults with major depressive disorder and treatment-resistant depression (TRD). Given psilocybin's psychedelic effects, all published studies have included psychological support. These effects depend on serotonin 2A (5-HT2A) receptor activation, which can be blocked by 5-HT2A receptor...

Physiological impact of breathing on health and stress level

Interdisciplinary Rehabilitation / Rehabilitacion Interdisciplinaria June 30, 2023 Dario R. Carestia, Andres F. Beltran, Francisco Cerdera et al. 27 citations

Introduction: there are numerous publications comparing the results, of a group of people who practice a particular type of meditation for a certain period of time, called the evaluation group, with another group of people who do not meditate, commonly referred to as the control group, and statistics such as confidence intervals, "p" value, etc. are presented. On the impact of meditation on...

The role of silence in the production of social order in meditation (on the example of vipassana)

RUDN Journal of Sociology June 30, 2023 A. K. Spirkina

The article considers silence as the most important component of vipassana (meditation technique from early Buddhism) as it is taught in the tradition of S.N. Goenka. As a religious vow, silence is a condition for the successful meditation retreat. Although meditative silence does not seem to form sociality, vipassana courses are a collective practice. After the end of courses, the desire of...

MINDFULNESS BASED STRESS REDUCTION (MBSR) TERHADAP PENURUNAN BURNOUT PADA PERAWAT

Jurnal Intervensi Psikologi June 30, 2023 Sarah Fatimah Azzahra, Evany Victoriana, Maria Yuni Megarini

ABSTRACT: Nurse is one of the professions engaged in the health sector and has a high intensity to deal directly with patients. The many responsibilities, the high complexity of the work and the demands that must be carried out by nurses make the nursing profession vulnerable to stress and burnout at work. This study aims to determine the effect of mindfulness-based interventions on reducing...

Classical psychedelics in psychiatry - renaissance of interest and therapeutic perspectives.

Psychiatria Polska June 30, 2023 Askaniusz Jachimowski, Krzysztof Kucia

Substances that change the states of consciousness have been used in the therapeutics of traditional cultures for hundreds of years. In the Western cultural circle, scientific curiosity and hope for a breakthrough in the treatment of various mental disorders constituted the basis of the first wave of research on humans with the use of psychedelics. After synthesizing LSD, psychedelic substances...

DOI: 10.12740/PP/150053 (opens in new tab) Full text (opens in new tab) Pharmacotheraphy Psychedelics hallucinogens Entheogens Psychoactive drugs +4

Case report: Psychedelic-induced seizures captured by intracranial electrocorticography

Frontiers in Neurology June 29, 2023 Benjamin N. Blond, Emmanuelle A. D. Schindler 11 citations

Classic psychedelics are currently re-emerging as therapeutic agents with unique clinical benefits; however, it is also important to recognize the adverse effects of this drug class. While the risk of seizures with this drug class is known, the literature is lacking in detail. We present a case of psychedelic mushroom-induced seizures in a person with refractory right temporal lobe epilepsy...

DOI: 10.3389/fneur.2023.1214969 (opens in new tab) Epilepsy Temporal lobe Adverse effect Anesthesia +2

Psychedelic Assisted Psychotherapy preparing your target using psychohistoriography: a Jamaican perspective

Frontiers in Psychiatry June 29, 2023 Winston de la Haye, Geoffrey Walcott, Jordan Eaton et al. 6 citations

The efficacy of psilocybin and other psychedelics as modes of treatment have been demonstrated through clinical trials and other studies in the management of a number of mental illnesses, including some treatment resistant cases. In Psychedelic Assisted Psychotherapy (PAP), psychedelics catalyze or enhance the experience fostered by psychotherapeutic methods. Psychohistoriographic Brief...

DOI: 10.3389/fpsyt.2023.1136990 (opens in new tab) Psychedelic therapy Psychedelic assisted psychotherapy New frontier Psychedelics +5